IESHA VIBERT: Open Payments
NPI 1548926041 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 38 payments from 9 companies in 2025. Trend: 2023 $238 · 2024 $963 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $215 |
| Otsuka America Pharmaceutical, Inc. | 8 | $151 |
| ABBVIE INC. | 10 | $144 |
| Supernus Pharmaceuticals, Inc. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $43 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $42 |
| OWP Pharmaceuticals, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $18 |
Products named: INVEGA SUSTENNA, VRAYLAR, REXULTI, Qelbree, COBENFY, CAPLYTA, SPRAVATO, Quviviq.
Industry payments across GA — which companies pay providers there.
